Songjiang Second News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Songjiang Second. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Songjiang Second Today - Breaking & Trending Today

Henlius Announces U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar Trastuzumab HLX02

Published: February 15, 2023

/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License...

Source: prnewswire.com

Related Topics:

United StatesUnited KingdomSaudi ArabiaJason ZhuPrnewswire Shanghai Henlius Biotech IncJacobson GroupAccord Biopharma IncEuropean CommissionDrug AdministrationIntas Pharmaceuticals LtdEuropean Medicines AgencyNational Medical Products AdministrationHenlius BiotechBiologics License ApplicationAccord BiopharmaXuhui FacilitySongjiang First PlantSongjiang SecondAccord HealthcareIntas PharmaceuticalsVisit AccordbiopharmaDrug ApplicationLicense ApplicationGood Manufacturing PracticeXuhui Plant